In contrast, there is no evidence that shows the potential effects of taking high amounts of vitamin B12 daily
Angiogenesis and vascular support: BPC-157 activates VEGFR2 while TB-500 promotes actin polymerization and endothelial migration together supporting robust neovascularization at injury sites
The combination is always chosen based on the patients specific symptom profile, not a generic protocol
Life changing! Who Should Consider B12/Lipotropic Injections
BPC-157 upregulates VEGF, EGF receptor expression, and the JAK-2/STAT-3 signaling pathway 5
The trial protocol was approved by the Madrid Region Clinical Research Ethics Committee ( Comit tico de Investigacin Clnica Regional de la Comunidad de Madrid ) on February 8 th 2011, and has been registered with ClinicalTrials.gov number NCT 01476007, and under EUDRACT number 2010-024129-20 [Oral Versus Intramuscular Cobalamin to treat Cobalamin Deficiency: Noninferiority randomised controlled trial, pragmatic and multi-center in the primary healthcare setting (OB12 project)]